Telenzepine

Telenzepine is a muscarinic antagonist that is used in the treatment of peptic ulcer disease. It is a selective M1 receptor antagonist that is primarily used in the treatment of gastrointestinal disorders. Telenzepine is not available in the United States, but is available in other countries, including Japan and the United Kingdom.

Pharmacology

Telenzepine is a muscarinic antagonist, which means it works by blocking the action of acetylcholine, a neurotransmitter that is involved in the contraction of smooth muscles and the secretion of gastric acid. By blocking the action of acetylcholine, telenzepine reduces the production of gastric acid, which can help to heal peptic ulcers and reduce symptoms of gastrointestinal disorders.

Telenzepine is a selective antagonist of the M1 subtype of muscarinic receptors. This means it has a greater affinity for M1 receptors than for other subtypes of muscarinic receptors. This selectivity makes telenzepine more effective in reducing gastric acid secretion than non-selective muscarinic antagonists.

Clinical use

Telenzepine is used in the treatment of peptic ulcer disease and other gastrointestinal disorders. It is not available in the United States, but is available in other countries, including Japan and the United Kingdom.

Side effects

The most common side effects of telenzepine are dry mouth, blurred vision, constipation, and urinary retention. These side effects are due to the blockade of muscarinic receptors in the salivary glands, eyes, gastrointestinal tract, and urinary tract.

See also

• Muscarinic antagonist
• Peptic ulcer disease
• Gastrointestinal disorders

Telenzepine Resources
Latest articles Most recent articles Ongoing trials	Wikipedia